TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: hemoglobin A1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Summary of Mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Summary of Mean Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correlation with air jet aesthesiometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type, frequency and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: change in hardness of dental caries lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documented suicide attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of force sensations in mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of days without asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants who experience at least one adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who discontinue study drug due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Tinnitus Functional Index (Chinese version)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cytokine Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-cell Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of Serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue Infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Secondary Antigen Spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV-free survival among infants exposed to HIV
Endpoint domain: Mortality/survival
Primary endpoint: Objective overall response rate (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fiber-type distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of AST and ALT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Seroprevalence of SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Neutrophil spontaneous oxidative burst
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Muscle regenerative capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: All-cause stroke
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Who Maintained Therapeutic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Maintained Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Sustained Therapeutic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 70% attendance or higher of HOPES groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Functional Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User satisfaction regarding the Adi pump functioning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Patients With Viral Load Less Than 400 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Allergy symptom severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychiatric symptom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the maximum urinary flow rate (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in the International Prostate Symptom Score (IPSS) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection rate of Gleason score ≥ 4+3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: survival rate percentage
Endpoint domain: Mortality/survival
Primary endpoint: NGAL kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of complete responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: rate of clinical responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pad position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Severe Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Hemidiaphragmatic paralysis before discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of development of keloids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Net blood glucose changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of adverse events of clinical interest
Endpoint domain: Adverse events/effects
Primary endpoint: microcirculatory reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major vascular groin-related complication
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in mean SBP and DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in neuropsychological assessments for memory and executive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of people vaccinated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in Gray Matter Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stress Perceptions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants With Long-term Engraftment of Allogeneic Stem Cells and Lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Acute and Chronic Graft-versus-host Disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of all malignant neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnosis of autism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bacteriologic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of breast cancer cases detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: macular hole closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating Serum Interleukin-6 (IL-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: High Frequency (.12 to .40 Hz) Heart Rate Variability Natural Log Transformed Paced Respiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: duration of voluntary activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Selectra 3D-related SADE-free rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects reporting Major Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of pre-cancerous and cancerous conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Successful HB pacing sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of CMV positive reactivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Muscle volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percent of Patients With ACR30 Flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Lipomas Dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Sleep Latency (Minutes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Average of Patient Global Impression of Severity (PGI-S)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average plasma concentration of PF-06372865
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events evaluated by NCI CTCAE V5.0
Endpoint domain: Adverse events/effects
Primary endpoint: YNQ Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardioprotective role
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right ventricle 2D strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of p62 protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of LC3I/II proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of beclin-1 protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Energy Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in FEV1 (Liters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: GBS status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Menstrual duration in days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast and Peak plasma concentration (Cmax) of Bepotastine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Slope of First Morning Urinary PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants With AE's
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Adverse Events (AE's)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of Social Needs
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Hedonic Ratings (pleasure)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stool microbiome diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of major drug-drug interactions
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of RFA
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention required to maintain cuff pressure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Functional Oral Intake Scale (FOIS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of deep venous thrombosis (DVT)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of nonfatal pulmonary embolism (PE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of symptomatic venous thromboembolic events (DVT, PE)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of HBV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: degree of disability or dependence in daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Need for Pain Relief
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Aging Males' Symptoms (AMS) scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of serum total testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: level of serum free testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in fMRI activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-time Hyperoxic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient-time Not on Room Air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Comprehension task - ability to identify healthy products
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Comprehension task - ability to identify unhealthy products
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: objective response rate (ORR) in subjects with p53WT MCC who have failed anti-PD-1 or anti-PDL-1 immunotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: objective response rate (ORR) in treatment-naïve subjects with p53WT MCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: confirmed overall response rate (ORR) based on IRC assessments in subjects with p53WT MCC who are chemotherapy naive and have failed anti-PD-1/PD-L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) of Deferitazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Deferitazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in aortic atherosclerotic plaque area and volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Percent Change in Ulcer Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients with mortality
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of glycemic control (A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Progression-free Patients
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of subjects with device in place showing lack of device migration or subsidence and absence of device related serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in pain score on the Visual Analog Scale (VAS) from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance or improvement of neurologic function related to the spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of subjects with lack of revision, removal, reoperation or use of additional supplemental fixation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in Oswestry Disability Index (ODI) score from baseline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in the Composite Score of MATRICS Consensus Cognitive Battery (MCCB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dramatic Worsening of Disease State as Assessed by PANSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gene expression changes in bone cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Effective Half-life of 111-In-CMD-193
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Serum Half-lives of 111-In-CMD-193
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Total Serum Clearance of 111-In-CMD-193
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in soccer neuromuscular training warm-up exercise self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SMFA score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Composite of pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Speech recognition testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sound quality judgements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vocal emotion perception task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Pain Numerical Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Pittsburgh Sleep Quality Index scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in TCD estimates of CBF measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Admissions to higher level of care
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Non-completion Rate of MRI Scans (All Scheduled Patients)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Non-completion Rate of MRI Scans (Showing-Up Patients Only)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Achieving ACR 50 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Ki-67 expression in malignant breast tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Change From Baseline in the Nighttime Symptom Score (NSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported Abstinence From Alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of patients with death or major disability
Endpoint domain: Mortality/survival
Primary endpoint: BASC scores (measures of general adjustment)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peds-QL 4.0 and 3.0 (quality of life assessments)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with abnormal, clinically significant hematology, clinical chemistry, and urinalysis laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in thiamin pyrophosphate effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of high-grade cervical abnormalities (CIN 2/3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients with ALP decrease > 40% or normal ALP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of days at home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Feasibility-response Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Days of Stimulant Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical Global Impression (CGI) Disease Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in EuroQol- 5 Dimension 3 Level Version (EQ-5D-3L) Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Score on Conners Adults ADHD Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hyperactivity as Measured by Aberrant Behavior Checklist - Hyperactivity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effects of disrupted sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood calcium levels on the 1st postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood calcium levels on the 2nd postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Length of hospital stay in days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: endothelial function change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change in Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of prescriptions filled for generic medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient adherence - Amount of prescriptions actually filled (Proportion of Days Covered)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximal percentage of bone marrow measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor skill gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Oxalate Absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Flash Electroretinogram (FERG) Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flash Electroretinogram (FERG) Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Glycosylated Hemoglobin A1c (HbA1c) at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes